Market Tracker

01/28 3:12pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

98.17
BATS BZX Real-Time Price
 -1.41 / -1.42%
Today’s Change
55.04
Today|||52-Week Range
100.95
+8.60%
Year-to-Date

Today’s Trading

Previous close99.58
Today’s open100.58
Day’s range97.19 - 100.95
Volume939,550
Average volume (3 months)1,246,154
Market cap$15.5B
Dividend yield--
Data as of 2:57pm ET, 01/28/2015

Growth & Valuation

Earnings growth (last year)-34.74%
Earnings growth (this year)+18.97%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+10.82%
P/E ratioNM
Price/Sales17.67
Price/Book10.65

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp-0.69-0.83%
PCYCPharmacyclics Inc+1.75+1.05%
MNKMallinckrodt Plc-0.80-0.75%
ENDPEndo International P...+1.71+2.14%
Data as of 3:12pm ET, 01/28/2015

Financials

Next reporting dateFebruary 19, 2015
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$548.4M
Annual profit (last year)-$176.4M
Net profit margin-32.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts